Rasagiline
Rasagiline (AGN1135) is a selective, irreversible monoamine oxidase B inhibitor used in Parkinson's disease research. It is studied as an adjunct to levodopa/carbidopa therapy and is applied in both in vitro enzymatic assays and in vivo models of neurodegeneration to investigate neuroprotective mechanisms.
Product Specifications
CAS Number
136236-51-6
Product Name Alternative
Rasagiline, TVP 1012, TVP1012, TVP-1012, AGN1135, AGN-1135, AGN 1135, (R) -AGN1135, Bcl-2, MonoamineOxidase, Monoamine Oxidase, inhibit, Inhibitor, MAO, MAO-B, MAO-A
Field of Research
Cell Biology, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
96.48% (May vary between batches)
Solubility
H2O:23.4 mM; DMSO:50 mg/mL (291.99 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (11.68 mM)
Smiles
C#CCN[C@@H]1CCC2=C1C=CC=C2
Molecular Formula
C12H13N
Molecular Weight
171.24
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
127431-FITC 100 µL
GNG7 (Guanine Nucleotide-binding Protein G (I) /G (S) /G (O) Subunit gamma-7, GNGT7, FLJ00058) (FITC)
Sign In for Pricing
View Details 